Jocelyn Ann-marie Rapelyea, MD | |
2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 | |
(202) 741-3398 | |
(202) 741-3396 |
Full Name | Jocelyn Ann-marie Rapelyea |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 29 Years |
Location | 2150 Pennsylvania Ave Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063583995 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | MD33124 (District Of Columbia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
George Washington Univ Hospital | Washington, DC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
George Washington University Medical Faculty Associates | 4082528898 | 651 |
News Archive
McKesson Corporation today reported that revenues for the first quarter ended June 30, 2010 were $27.5 billion compared to $26.7 billion a year ago. First-quarter earnings per diluted share was $1.10 compared to $1.06 per diluted share a year ago.
Merrimack Pharmaceuticals, Inc. today announced that Phase I data evaluating the novel agent MM-302 for the treatment of advanced HER2+ breast cancer and preclinical data on potential imaging and biomarker-based diagnostics will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), Dec. 4-8, 2012 in San Antonio, Texas.
A new laser-based technology may make brain tumor surgery much more accurate, allowing surgeons to tell cancer tissue from normal brain at the microscopic level while they are operating, and avoid leaving behind cells that could spawn a new tumor.
Postnova Analytics reports on exciting advances in the analysis of plasma proteins using a hyphenated system that couples asymmetric flow Field-Flow Fractionation (AF4) and inductively coupled plasma-mass spectrometry.
› Verified 7 days ago
Entity Name | Medical Faculty Associates, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
McKesson Corporation today reported that revenues for the first quarter ended June 30, 2010 were $27.5 billion compared to $26.7 billion a year ago. First-quarter earnings per diluted share was $1.10 compared to $1.06 per diluted share a year ago.
Merrimack Pharmaceuticals, Inc. today announced that Phase I data evaluating the novel agent MM-302 for the treatment of advanced HER2+ breast cancer and preclinical data on potential imaging and biomarker-based diagnostics will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), Dec. 4-8, 2012 in San Antonio, Texas.
A new laser-based technology may make brain tumor surgery much more accurate, allowing surgeons to tell cancer tissue from normal brain at the microscopic level while they are operating, and avoid leaving behind cells that could spawn a new tumor.
Postnova Analytics reports on exciting advances in the analysis of plasma proteins using a hyphenated system that couples asymmetric flow Field-Flow Fractionation (AF4) and inductively coupled plasma-mass spectrometry.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Jocelyn Ann-marie Rapelyea, MD 2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 Ph: (202) 741-3398 | Jocelyn Ann-marie Rapelyea, MD 2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 Ph: (202) 741-3398 |
News Archive
McKesson Corporation today reported that revenues for the first quarter ended June 30, 2010 were $27.5 billion compared to $26.7 billion a year ago. First-quarter earnings per diluted share was $1.10 compared to $1.06 per diluted share a year ago.
Merrimack Pharmaceuticals, Inc. today announced that Phase I data evaluating the novel agent MM-302 for the treatment of advanced HER2+ breast cancer and preclinical data on potential imaging and biomarker-based diagnostics will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), Dec. 4-8, 2012 in San Antonio, Texas.
A new laser-based technology may make brain tumor surgery much more accurate, allowing surgeons to tell cancer tissue from normal brain at the microscopic level while they are operating, and avoid leaving behind cells that could spawn a new tumor.
Postnova Analytics reports on exciting advances in the analysis of plasma proteins using a hyphenated system that couples asymmetric flow Field-Flow Fractionation (AF4) and inductively coupled plasma-mass spectrometry.
› Verified 7 days ago
Kimberly Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 301-902-1073 | |
Dr. Michael B Shvarts, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Joel Bowers, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-269-7000 | |
Krista Lyn Mcfarren, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3301 New Mexico Ave Nw, Suite 102, Washington, DC 20016 Phone: 202-966-0606 Fax: 202-244-6757 | |
Ranjith Vellody, MD Radiology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Aaron Conard, Radiology Medicare: Not Enrolled in Medicare Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 240-366-7325 | |
Dr. Estelle Cooke-sampson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw Ste 6101, Washington, DC 20060 Phone: 202-865-6679 Fax: 202-865-3138 |